Quantification of HIV and AIDS Commodities for the Period April 2015 through March 2017, Swaziland
(2014; 32 pages)

Shiferaw G., Matshotyana K., Mthetwa T. 2014. Quantification of HIV and AIDS Commodities for the Period April 2015 through March 2017, Swaziland. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.

Abrégé

Swaziland faces daunting health challenges. It has the highest HIV prevalence rate in the world at 31% of people aged 15 to 49 years. HIV and AIDS are the greatest public health and socio-economic development challenges for the country. The Government of Swaziland (GOS) has made significant progress addressing the epidemic through the implementation of a series of strategic plans and frameworks. A regular and systematic quantification of HIV and AIDS commodities is one of the essential interventions to ensure that adequate resources are available without interruption. The scope of this quantification was national, covering all HIV and AIDS commodities procured with government funding. Commodities that were quantified included: antiretroviral (ARV) medicines for antiretroviral treatment (ART) and prevention of mother-to-child transmission (PMTCT); medicines for opportunistic infections, such as cotrimoxazole prophylaxis; medicines for isoniazid preventive therapy (IPT), such as isoniazid (INH); and medicines for Kaposi sarcoma.

 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018